Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics-Reference-Cited by-同舟云学术

Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics

Published:2019-10-01 Issue:10 Volume:76 Page:1052
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Masuda Takahiro¹²,Misawa Fuminari¹³,Takase Masayuki¹⁴,Kane John M.¹⁵⁶,Correll Christoph U.¹⁵⁶⁷

Affiliation:

1. Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York

2. Sumitomo Dainippon Pharma Co, Ltd, Medical Affairs, Tokyo, Japan

3. Yamanashi Prefectural KITA Hospital, Yamanashi, Japan

4. Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan

5. Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York

6. Feinstein Institute for Medical Research, Manhasset, New York

7. Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2738765/jamapsychiatry_masuda_2019_oi_190041.pdf

Reference65 articles.

1. Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology.;Howes;Am J Psychiatry,2017

2. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia.;Falkai;World J Biol Psychiatry,2005

3. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.;Galletly;Aust N Z J Psychiatry,2016

4. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.;Leucht;Lancet,2013

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review;Expert Opinion on Drug Safety;2024-09-03

2. Association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: A systematic review and meta-analysis;Schizophrenia Research;2024-09

3. Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission;British Journal of Pharmacology;2024-08-02

4. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice;European Neuropsychopharmacology;2024-07

5. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis;CNS Drugs;2024-07-01